ENTITY

ABLBio (298380 KS)

41
Analysis
Health Care • South Korea
ABLBio, Inc. operates as a drugs development company. The Company develops and manufactures neurodegenerative diseases therapeutic drugs, oncology therapeutic drugs, and other products. ABLBio markets its products throughout Korea.
more
Exchange Announcement • 28 Jul 2026 14:05

[Revised] Material Management Information related to Judgment of Investment(Approval for IND Modification)(이중항체 ë©´ì—­í•­ì•”ì œ ABL503의 ì œ1상 임상시험계획 (IND) 변경승인)

Exchange Announcement • 09 Jul 2026 14:34

Material Management Information related to Judgment of Investment(Approval for IND Modification)(이중항체 ë©´ì—­í•­ì•”ì œ ABL503의 ì œ1상 임상시험계획 (IND) 변경승인)

Exchange Announcement • 02 Jul 2026 12:28

Organization of Investor Relations Event

Exchange Announcement • 02 Jul 2026 12:27

Organization of Investor Relations Event

Exchange Announcement • 02 Jul 2026 12:26

Organization of Investor Relations Event

x